Phase I study of adavosertib with radiation therapy and temozolomide in newly diagnosed glioblastoma and intratumoral drug levels in recurrent glioblastoma.
Lee EQ, Alexander BM, Romo CG, Supko JG, Agar NYR, Talebi Z, Ahluwalia MS, Desai AS, Dietrich J, Kaley TJ, Peereboom DM, Gantchev J, Baquer G, Santagata S, Takebe N, Desideri S, Fisher JD, Sims M, Ye X, Ligon KL, Nabors LB, Grossman SA, Wen PY.
Lee EQ, et al. Among authors: ye x.
Clin Cancer Res. 2025 Jan 17. doi: 10.1158/1078-0432.CCR-24-2311. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39820282